ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 50

Human Chondrocyte Dedifferentiation Is Accompagnied by CD105 Endoglin Expression, ALK-1/Smad1/5 Phosphorylation and Leptin Production – Stimulation by Prednisolone and Aldosterone Through the Glucocorticoid Receptor

Olivier Malaise1, Biserka Relic2, Mustapha Zeddou1, Edith Charlier1, Florence Quesada Calvo1, Sophie Neuville3, Dominique de Seny2 and Michel G. Malaise4, 1Department of Rheumatology, GIGA Research - University of Liège - CHU Liège, Liège, Belgium, 2Department of Rheumatology, GIGA Research - University of Liège - CHU of Liège, Liège, Belgium, 3GIGA Research - University of Liège - CHU of Liège, Liège, Belgium, 4Department of Rheumatology, University of Liège - CHU Liège, Liège, Belgium

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: chondrocytes, glucocorticoids, Inflammation, Mesenchymal stem cells and osteoarthritis

  • Tweet
  • Email
  • Print
Session Information

Title: Biology and Pathology of Bone and Joint

Session Type: Abstract Submissions (ACR)

Background/Purpose:  

Leptin, mainly produced by the adipose tissue including fat neighboring the joint, is considered as pro-inflammatory in osteoarthritis (OA). Normal cartilage does not express leptin, while OA cartilage is a potential producer. We recently showed that joint derived-cells such as synovial fibroblasts (SF), but also bone marrow mesenchymal stem cells, were able to spontaneously produce leptin in vitro, strongly enhanced by glucocorticoids (prednisolone and dexamethasone) involving the ALK-1/Smad1/5 pathway as inducer and the ALK-5/Smad2 pathway as inhibitor. In this work, we have tested isolated human chondrocytes (CH) for leptin, leptin receptor (Ob-R) and balance ALK-5/Smad2 – ALK-1/Smad1/5, during dedifferentiation process. Secondly, we have studied if the glucocorticoid prednisolone and the mineralocorticoid aldosterone were able to induce leptin and Ob-R expression as well as the involvement of the glucocorticoid receptor (GR) or/and mineralocorticoid  receptor (MR). 

Methods:

Humain CH were obtained during joint replacement. To detect surface antigens, cells were immunolabelled with the following anti-human antibodies: CD90–APC, CD105–PE, CD73–PE and analysed on a FACS-CANTO with the CellQuest software. Cells were stimulated with prednisolone, aldosterone, mifepristone (GR inhibitor), spironolactone and epleronone (MR inhibitors) or TGF-β1. Leptin was determined by ELISA, while Ob-R expression, Smad1/5 phosphorylation, Smad2 phosphorylation, ALK-1 and ALK-5 were determined by Western blot.

Results:

1. Primary (PCH) and dedifferentiated (DCH) chondrocytes were similarly positive for CD90 (98.5% ± 1.5 and 99.4% ± 0.3, respectively) and CD73 (84.9% ± 24 and 98.9 ± 0.2, respectively), whereas DCH significantly increased their CD105 (endoglin) expression (33.7% ± 21 and 68.6% ± 17.8, P=0,004). 2. PCH did not produce leptin nor expressed Ob-R. Opposite, DCH significantly expressed leptin and Ob-R. Both leptin and Ob-R expressions were markedly induced by prednisolone. TGF-β1 significantly downregulated prednisolone-induced leptin and Ob-R. With chondrocyte dedifferenciation, ALK-5/Smad2 phosphorylation was progressively decreasing, while ALK-1/Smad1/5 phosphorylation was increasing. 3. Aldosterone, as prednisolone, significantly induced leptin and Ob-R expression in DCH, both stimulations significantly downregulated with the GR inhibitor mifepristone, but not with MR inhibitors spironolactone and eplerenone.

Conclusion:  

1. PCH expressed low levels of CD105 endoglin, exhibited an ALK-5/Smad2 phosphorylation and did not produce leptin nor Ob-R 2. On the contrary, DCH significantly increased their capacity to express CD105 endoglin, exhibited an ALK-1/Smad1/5 phosphorylation, and spontaneously produced leptin and Ob-R. 2. Leptin and Ob-R expressions were inhibited by TGF-β1, but markedly increased by the glucocorticoid prednisolone and the mineralocorticoid aldosterone. 4. Prednisolone and aldosterone increased leptin and Ob-R expressions through GR but not MR stimulation.


Disclosure:

O. Malaise,
None;

B. Relic,
None;

M. Zeddou,
None;

E. Charlier,
None;

F. Quesada Calvo,
None;

S. Neuville,
None;

D. de Seny,
None;

M. G. Malaise,
None.

  • Tweet
  • Email
  • Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/human-chondrocyte-dedifferentiation-is-accompagnied-by-cd105-endoglin-expression-alk-1smad15-phosphorylation-and-leptin-production-stimulation-by-prednisolone-and-aldosterone-through-the-gl/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology